Once “undruggable,” now very druggable! Our new Trends in Cancer commentary explores how next-gen RAS inhibitors are rewriting the rules of precision oncology - from allele-specific RNAi to dual-state KRAS degraders. 🔗 authors.elsevier.com/a/1m0YQ8Z12y... #RAS #PrecisionOncology #DrugDevelopment

A busy day at #AACR25 in Chicago! Make sure to follow the #PancreaticCancer presentations throughout the day to keep up to date with the latest scientific discoveries. #ColumbiaCancer Catch me at my poster (section 3, board 5) later!

Night Science with @kelseymonson.bsky.social, @itaiyanai.bsky.social and @stearnslab.bsky.social at Mount Sinai! The perfect place to learn how the words you use to describe your science influences your ability to think beyond the scope. This is your chance to meet Postdocs from all over NYC!

Is hypothesis generation a hindrance to Night Science? @itaiyanai.bsky.social and @stearnslab.bsky.social demonstrated how easy we fall into pattern recognition, missing the “Gorilla” in our own data. Today’s seminar was all about identifying new strategies to stay curious about our own data.